Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells

International Journal of Molecular Medicine

Volumn 30, Issue 4, 2012, Pages 945-952

  Lee, Se Jung ^a,b,c   Kim, Wun Jae ^c   Moon, Sung Kwon ^a,c  

^a Chungju National University   (South Korea)

^b Chung Ang University   (South Korea)

^c Chungbuk National University   (South Korea)

Author keywords

Bladder cancer cells; Interleukin 28A; Matrix metalloproteinases 9; Migration; p38 MAPK

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AP 1 PROTEIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 28A; JANUS KINASE 2; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BINDING AFFINITY; BLADDER CANCER; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; SIGNAL TRANSDUCTION; WOUND HEALING; WOUND HEALING MIGRATION ASSAY; ZYMOGRAPHY;

CELL LINE, TUMOR; CELL MOVEMENT; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMIDAZOLES; INTERLEUKINS; JANUS KINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASMS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; SIGNAL TRANSDUCTION; STAT2 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1; URINARY BLADDER;

EID: 84866489316     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1064     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, Murray E, Xu T and Thun MJ: Cancer statistics. CA Cancer J Clin 57: 43-66, 2007.
2. Black PC and Dinney CP: Bladder cancer angiogenesis and metastasis - translation from murine model to clinical trial. Cancer Metastasis Rev 26: 623-634, 2007.
3. Metts MC, Metts JC, Milito SJ and Thomas CR Jr: Bladder cancer: a review of diagnosis and management. J Natl Med Assoc 92: 285-294, 2000.
4. Crawford JM: The origins of bladder cancer. Lab Invest 88: 686-693, 2008.
5. Heney NM, Proppe K, Prout GR, Griffin PP and Shipley WU: Invasive bladder cancer: tumor figuration, lymphatic invasion and survival. J Urol 130 : 895-897, 1983.
6. Mitra AP, Bartsch CC and Cote RJ: Strategies for molecular expression profiling in bladder cancer. Cancer Metastasis Rev 28: 317-326, 2009.
7. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573, 1993.
8. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125, 1990.
9. Westermarck J and Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
10. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A and Balkwill F: Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369, 1993.
11. Bianco FJ, Gervasi DC Jr, Tiguert R, Grignon DJ, Pontes JE, Crissman JD, Fridman R and Wood DP Jr: Matrix metalloproteinase- 9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade. Clin Cancer Res 4: 3011-3016, 1998.
12. Mook OR, Frederiks WM and Van Noorden CJ: The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89, 2004.
13. Bond M, Rosalind P, Fabunmi P, Baker AH and Newby AC: Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 435: 29-34, 1998.
14. Sato H and Seiki M: Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405, 1993.
15. Moon SK, Cha BY and Kim CH: ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. J Cell Physiol 198: 417-427, 2004.
16. Kim S, Choi JH, Lim HI, Lee SK, Kim WW, Cho S, Kim JS, Kim JH, Choe JH, Nam SJ, et al: EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line. Cell Signal 21: 892-898, 2009.
17. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H and Donnelly RP: IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77, 2003.
18. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, et al: IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68, 2003.
19. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diebold J, Diepolder H, Adler B, Auernhammer CJ, et al: IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 289: G960-G968, 2005.
20. Yang L, Luo Y, Wei J and He S: Integrative genomic analyses on IL28RA, the common receptor of interferon-λ1, -λ2 and -λ3. Int J Mol Med 25: 807-812, 2010.
21. Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, Tian B, Reuhl K, Dickensheets H, Sheikh F, Donnelly RP, et al: Characterization of the mouse IFN-λ ligand-receptor system: IFN-λs exhibit antitumor activity against B16 melanoma. Cancer Res 66: 4468-4477, 2006.
22. Numasaki M, Tagawa M, Iwata F, Suzuki T, Nakamura A, Okada M, Iwakura Y, Aiba S and Yamaya M: IL-28 elicits antitumor responses against murine fibrosarcoma. J Immunol 178: 5086-5098, 2007.
23. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
24. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
25. Okamoto M, Hattori K and Oyasu R: Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer 72: 149-154, 1997.
26. Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R and Dinney CP: Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res 60: 2290-2299, 2000.
27. Lee SJ, Park SS, Cho YH, Park K, Kim EJ, Jung KH, Kim SK, Kim WJ and Moon SK: Activation of matrix metalloproteinase-9 by TNF-α in human urinary bladder cancer HT1376 cells: The role of MAP kinase signaling pathways. Oncol Rep 19: 1007-1013, 2008.
28. Lee SJ, Park SS, Lee US, Kim WJ and Moon SK: Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells. Int Immunopharmacol 8: 1821-1826, 2008.